Skip to content

Comparision the analgesic effects of intravenous acetaminophen , intramuscular tramadol and suppository diclofenac in the treatment of cesarean pain

Comparision the analgesic effects of intravenous acetaminophen , intramuscular tramadol and suppository diclofenac in the treatment of cesarean pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201301235448N3
Enrollment
105
Registered
2013-04-10
Start date
2013-01-29
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility. Female Infertility

Interventions

Intervention 1: Group1 versus rectal diclofenac 100 mg every 8 hours (made ??in Iran, drug manufacturing company). Intervention 2: In group2: IV Acetaminophen 1g/100ml infusion for 15 minutes every 6
Treatment - Drugs
Group1 versus rectal diclofenac 100 mg every 8 hours (made ??in Iran, drug manufacturing company)
In group2: IV Acetaminophen 1g/100ml infusion for 15 minutes every 6 hours in patients over 50 kg. In patients under 50 kg, 15 mg / kg every 6 hours (making Iran Couble medicine)
In group3: muscle tramadol 50mg injections every 8 hours (made in Iran, drug manufacturing company) will be used

Sponsors

Tabriz University of Medical Mciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1 - Pregnant women who are candidates for elective or emergency cesarean section to link to the list of operating room training center - Al Zahra Hospital, Tabriz and taleghany hospital have been. 2 - pregnant women over 34 weeks 3 - patient willingness to participate in the study exclusion criteria of study: 1 - Patients who have any reason to take any pain medications before surgery. 2 - Have the contra indications for NSAID or paracetamol or tramadol prescription, such as peptic ulcer, coagulopathy, renal failure, liver failure, asthma, and allergy medicines .... 3 - a history of mental problems and anxiety

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain Relief. Timepoint: Pain of 2 hours, 6 hours and 24 hours after surgery is measured. Method of measurement: Visual assay of pain (VAS) by scaled ruler (0 to 10) is zero, no pain and 10 the worst pain at the show, be assesse.

Secondary

MeasureTime frame
Improve mobility. Timepoint: Up to 8 hours after surgery. Method of measurement: Questionnaire.;Reduce the risk of postoperative thromboembolic disease. Timepoint: After Surgery. Method of measurement: Questionnaire.;Improve the ability of the mother to child care and breastfeeding. Timepoint: After Surgery. Method of measurement: Questionnaire.;Shorten the period of hospitalization. Timepoint: After Surgery. Method of measurement: Questionnaire.;Reduce hospital costs And increase patient satisfaction. Timepoint: After Surgery. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactD.Fatemeh Mallah

Tabriz University of Medical Sciences

wrhrcenter@gmail.com+98 41 1553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026